TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Nov 18, 4:01 PM ET

Fox Christine 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Nov 18, 2025

Insider Transaction Report

Form 4
Period: 2025-11-14
Fox Christine
EVP, U.S. Commercial
Transactions
  • Sale

    Ordinary Shares

    2025-11-14$25.11/sh30,000$753,32128,384 total
Footnotes (1)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4